Status: current, Primitive. Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4636040011 | Teneligliptin (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4636041010 | Teneligliptin | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Teneligliptin | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Teneligliptin | Is a | Dipeptidyl peptidase IV inhibitor | true | Inferred relationship | Some | ||
| Teneligliptin | Is a | Carboxylic acid and/or carboxylic acid derivative | true | Inferred relationship | Some | ||
| Teneligliptin | Has disposition | Dipeptidyl peptidase IV inhibitor | true | Inferred relationship | Some | ||
| Teneligliptin | Is a | Drug or medicament | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Teneligliptin hydrobromide | Is modification of | True | Teneligliptin | Inferred relationship | Some | |
| Teneligliptin (as teneligliptin hydrobromide) 20 mg oral tablet | Has BoSS | True | Teneligliptin | Inferred relationship | Some | 1 |
| Teneligliptin only product in oral dose form | Has active ingredient | True | Teneligliptin | Inferred relationship | Some | 1 |
| Teneligliptin-containing product in oral dose form | Has active ingredient | True | Teneligliptin | Inferred relationship | Some | 1 |
| Teneligliptin-containing product | Has active ingredient | True | Teneligliptin | Inferred relationship | Some | 1 |
| Teneligliptin only product | Has active ingredient | True | Teneligliptin | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR